Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about VASCULAR DEMENTIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | VASCULAR DEMENTIA |
| Key Genes/Proteins | APOE, APP, CREB, MMP9 |
| Related Diseases | GLUTAMATE, GLYCOLYSIS, NEUROINFLAMMATION |
| Related Pathways | NLRP3 INFLAMMASOME |
graph TD
VASCULAR_DEMENTIA["VASCULAR DEMENTIA"]
style VASCULAR_DEMENTIA fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
VASCULAR_DEMENTIA -->|"causes"| Cerebrovascular["Cerebrovascular"]
VASCULAR_DEMENTIA -->|"activates"| Blood_Brain_Barrier["Blood-Brain Barrier"]
VASCULAR_DEMENTIA -.->|"inhibits"| Myelination["Myelination"]
VASCULAR_DEMENTIA -.->|"inhibits"| Apoptosis["Apoptosis"]
VASCULAR_DEMENTIA -.->|"inhibits"| Inflammasome["Inflammasome"]
VASCULAR_DEMENTIA -->|"activates"| Dendritic_Spine["Dendritic Spine"]
VASCULAR_DEMENTIA -->|"activates"| Camp_Signaling["Camp Signaling"]
VASCULAR_DEMENTIA -.->|"inhibits"| Amyloid["Amyloid"]
Chronic_Cerebral_Hypoperfusion["Chronic Cerebral Hypoperfusion"] -->|"causes"| VASCULAR_DEMENTIA
FERROPTOSIS["FERROPTOSIS"] -->|"contributes to"| VASCULAR_DEMENTIA
CHRONIC_CEREBRAL_HYPOPERFUSION["CHRONIC CEREBRAL HYPOPERFUSION"] -->|"causes"| VASCULAR_DEMENTIA
Tong_Qiao_Huo_Xue_Decoction{"Tong-Qiao-Huo-Xue Decoction"} -->|"treats"| VASCULAR_DEMENTIA
Cerebrovascular_Disease["Cerebrovascular Disease"] -->|"risk_factor_for"| VASCULAR_DEMENTIA
NLRP3([NLRP3]) -->|"contributes to"| VASCULAR_DEMENTIA
Ams_17["Ams-17"] -->|"treats"| VASCULAR_DEMENTIA
AMS_17["AMS-17"] -->|"treats"| VASCULAR_DEMENTIA
A3AR["A3AR"] -->|"treats"| VASCULAR_DEMENTIA| Target | Relation | Type | Str |
|---|---|---|---|
| Tau Protein Hyperphosphorylation | associated_with | mechanism | 0.90 |
| Blood-Brain Barrier Dysfunction | associated_with | phenotype | 0.85 |
| NLRP3 | associated_with | protein | 0.85 |
| ALZHEIMER'S DISEASE | associated_with | entity | 0.85 |
| Vitamin D | associated_with | chemical | 0.70 |
| blood-brain barrier | affects | brain_region | 0.60 |
| ferroptosis | involves | pathway | 0.60 |
| white matter | affects | brain_region | 0.60 |
| endothelial cells | affects | cell_type | 0.60 |
| lipid metabolism | involves | pathway | 0.60 |
| neural stem cells | affects | cell_type | 0.60 |
| Neuron | therapeutic_target | cell_type | 0.55 |
| Ferroptosis | associated_with | pathway | 0.55 |
| Cerebrovascular | causes | pathway | 0.55 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.55 |
| Endothelial | therapeutic_target | cell_type | 0.55 |
| Inflammasome | therapeutic_target | pathway | 0.55 |
| Apoptosis | therapeutic_target | pathway | 0.55 |
| Neuron | activates | cell_type | 0.55 |
| Endothelial | associated_with | cell_type | 0.55 |
| Oxidative Stress | therapeutic_target | pathway | 0.55 |
| Amyloid | associated_with | pathway | 0.55 |
| Blood-Brain Barrier | activates | pathway | 0.55 |
| Myelination | inhibits | pathway | 0.55 |
| Apoptosis | inhibits | pathway | 0.55 |
| Inflammasome | inhibits | pathway | 0.55 |
| Blood-Brain Barrier | inhibits | pathway | 0.55 |
| Apoptosis | activates | pathway | 0.55 |
| Dendritic Spine | activates | pathway | 0.55 |
| Camp Signaling | activates | pathway | 0.55 |
| Amyloid | inhibits | pathway | 0.55 |
| Calcium Signaling | expressed_in | pathway | 0.55 |
| Blood-Brain Barrier | causes | pathway | 0.55 |
| Cerebrovascular | associated_with | pathway | 0.55 |
| Oxidative Stress | interacts_with | pathway | 0.55 |
| Amyloid | interacts_with | pathway | 0.55 |
| Blood-Brain Barrier | interacts_with | pathway | 0.55 |
| Sod1 | interacts_with | pathway | 0.55 |
| Oligodendrocyte | interacts_with | cell_type | 0.55 |
| Opc | interacts_with | cell_type | 0.55 |
| APP | associated_with | gene | 0.50 |
| APOE | associated_with | gene | 0.50 |
| Cortex | associated_with | brain_region | 0.50 |
| White Matter | associated_with | brain_region | 0.50 |
| Hippocampus | associated_with | brain_region | 0.50 |
| CREB | associated_with | gene | 0.45 |
| PREFRONTAL CORTEX | associated_with | brain_region | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Chronic Cerebral Hypoperfusion | causes | process | 0.95 |
| FERROPTOSIS | contributes_to | entity | 0.95 |
| Tong-Qiao-Huo-Xue Decoction | treats | drug | 0.95 |
| CHRONIC CEREBRAL HYPOPERFUSION | causes | entity | 0.95 |
| cardiovascular disease | causes | disease | 0.90 |
| Nerve cell damage | contributes_to | phenotype | 0.90 |
| NLRP3 | contributes_to | protein | 0.90 |
| Chronic Cerebral Hypoperfusion | contributes_to | disease | 0.90 |
| Cerebrovascular Disease | risk_factor_for | disease | 0.90 |
| Ams-17 | treats | compound | 0.85 |
| Oligodendrocytes | involved_in | cell_type | 0.85 |
| PAL | treats | compound | 0.85 |
| BDNF | biomarker_for | protein | 0.80 |
| TNF-α | biomarker_for | protein | 0.80 |
| A3AR | treats | receptor | 0.80 |
| Ferroptosis | accelerates | process | 0.80 |
| MMP9 | contributes_to | protein | 0.75 |
| FERROPTOSIS | effect_on | process | 0.70 |
| NEUROINFLAMMATION | inhibits | gene | 0.65 |
| AMYOTROPHIC LATERAL SCLEROSIS | contributes_to | gene | 0.65 |
| TNF | inhibits | gene | 0.65 |
| PARKINSON | contributes_to | gene | 0.65 |
| IL-4 | inhibits | gene | 0.65 |
| NEURODEGENERATIVE DISEASES | contributes_to | gene | 0.65 |
| APOPTOSIS | inhibits | gene | 0.65 |
| PARKINSON'S DISEASE | contributes_to | gene | 0.65 |
| ALS | contributes_to | gene | 0.65 |
| TNF-Α | inhibits | gene | 0.65 |
| ASC | contributes_to | gene | 0.65 |
| EXOSOMES | inhibits | gene | 0.65 |
| ALZHEIMER | inhibits | gene | 0.65 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.65 |
| AMYLOID | inhibits | gene | 0.65 |
| TAU | inhibits | gene | 0.65 |
| DEMENTIA | protects_against | gene | 0.65 |
| APOE | interacts_with | gene | 0.65 |
| INFLAMMATION | interacts_with | gene | 0.65 |
| SOD1 | interacts_with | gene | 0.65 |
| TNF | interacts_with | gene | 0.65 |
| CLDN5 | interacts_with | gene | 0.65 |
| NATURAL COMPOUNDS | interacts_with | gene | 0.65 |
| OXIDATIVE STRESS | interacts_with | gene | 0.65 |
| MMP9 | interacts_with | gene | 0.65 |
| IL-17 | interacts_with | gene | 0.65 |
| AND | protects_against | gene | 0.65 |
| APLP1 | interacts_with | gene | 0.65 |
| AMYLOID | interacts_with | gene | 0.65 |
| GLYCOLYSIS | causes | phenotype | 0.65 |
| AND | causes | gene | 0.65 |
| SERPINE2 | interacts_with | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| C1Q-Glia Cross-Talk in Vascular Dementia Pathogenesis | 0.470 | neuroinflammation | What are the specific molecular mechanis |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning VASCULAR DEMENTIA in their description or question text
No additional research found